CClinicalTrials.gg
CompletedNCT05144737Updated Apr 23, 2026Results posted

A Virtual Cardiometabolic Health Program for African Immigrants: The Afro-DPP Program

An interventional study of The Diabetes Prevention Program in Diabetes Mellitus, Diabetes Mellitus, Type 2 and PreDiabetes, sponsored by Johns Hopkins University. Completed at 1 site in United States. Open to participants aged 25 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-04-23.

Sponsored by Johns Hopkins University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
25 Years to 75 Years
Sex
All
01

Study summary

A pilot study titled "A Virtual Cardiometabolic Health Program for African Immigrants (The Afro-DPP Program) will be conducted to address the cardiometabolic of community-dwelling African immigrants who have multiple cardiometabolic risk factors including hypertension, Type 2 Diabetes, high cholesterol, and overweight/obesity. The proposed study will recruit a total of 60 participants and will use a non-equivalent control group design to test the effectiveness of the intervention at two African churches in the Baltimore, Washington, D.C. area. The two churches will be randomly assigned to the intervention or delayed intervention group. At the end of a 6-month follow-up period, the control church will receive the intervention (delayed control group). All participants will receive a Bluetooth-enabled digital scale (Omron Model: BCM-500) that measures body composition including Body Weight, Body Fat percentage, Visceral Fat, Skeletal Muscle percentage, Resting Metabolism and Body Mass Index. A Bluetooth-enabled blood pressure monitor (Omron Model: BP7250) will also be distributed to all participants. All participants will download the Omron Connect app which will allow the participants to sync participants' blood pressure readings and body composition readings into the app. The research team will access these readings to monitor study outcomes and participants progress during the follow-up period.

02

Conditions studied

  • Diabetes Mellitus
  • Diabetes Mellitus, Type 2
  • PreDiabetes
  • Hypertension
  • High Blood Pressure
  • High Blood Sugar
  • Obesity
  • Overweight
  • Overweight and Obesity
  • Overweight or Obesity

Keywords

  • African immigrant
  • Prediabetes
  • National Diabetes Prevention Program
03

In context

Diabetes Mellitus

10,925 studies on the registry are indexed under Diabetes Mellitus; 1,319 are open to participants now.

This study's enrollment of 60 is below the median of 80 across 8,367 interventional studies indexed under Diabetes Mellitus.

Browse Diabetes Mellitus studies →

Lead sponsor

Johns Hopkins University is the lead sponsor of 1,783 studies on the registry; 313 are open to participants now.

Of its 203 completed or terminated interventional studies of FDA-regulated products, 140 (69%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • African immigrants who are aged 25-75 years
  • Participants who report being uninsured or have no access to a healthcare provider
  • Have at least two of the following chronic conditions:
  • Body-mass index ≥ 25 kg/m2
  • Self-reported fasting plasma glucose of 95 to 125 mg/d or HbA1c of 5.7-6.5% in the past 6 months
  • Systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥ 90 mmHg

Exclusion criteria

Exclusion Criteria:

  • Participants who cannot communicate in English
  • Participants who have cognitive challenges that would restrict them from participation
  • Participants who have any serious illness that would interfere with participation
  • Participants who are not members of the churches that are involved in this study
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
60 participants (actual)

Study arms

  • Other
    Immediate Intervention Group

    Participants in the immediate intervention group will immediately begin 6 months of the adapted DPP lifestyle intervention with a Lifestyle Coach and remote monitoring of blood pressure and body composition. This will be followed by a 6-month observation period where the intervention (Lifestyle Coach) will be withdrawn. In this period, participants will be evaluated for the maintenance of lifestyle changes.

    Behavioral: The Diabetes Prevention Program

  • Other
    Delayed Intervention Group

    Participants in the delayed intervention group will receive remote monitoring of blood pressure and body composition for the 1st 6 months (without the Lifestyle Coach) and then will receive the adapted DPP lifestyle intervention with a Lifestyle Coach after 6 months.

    Behavioral: The Diabetes Prevention Program

Interventions

  • BehavioralThe Diabetes Prevention Program

    The multicomponent intervention will focus on intensive lifestyle modification delivered by the Lifestyle Coach. The Lifestyle Coach of African origin will be responsible for delivering the intensive lifestyle intervention and implementing the adapted diabetes prevention program (DPP) curriculum.

06

What researchers measure

Primary outcomes

  1. Change in Diastolic Blood Pressure (mm/Hg) Over a 6-month Period

    Change was calculated as 6 months minus the baseline value

    Time frame: Baseline, 6 months

  2. Change in Systolic Blood Pressure (mm/Hg) Over a 6-month Period

    Change was calculated as 6 months minus the baseline value

    Time frame: Baseline, 6 months

  3. Change in Body Weight in Kilograms (kg) Over a 6-month Period

    Change was calculated as 6 months minus baseline value

    Time frame: Baseline, 6 months

  4. Change in Body Mass Index Over a 6-month Period

    Change was calculated as 6 months minus the baseline value

    Time frame: Baseline, 6 months

Other outcomes

  1. Change in Quality of Life Over the 12-month Period

    A validated tool by the name of PROMIS global measure will be provided by the Patient-Reported Outcomes Measurement Information System (PROMIS). This 9 items on this tool will measure the participants' fatigue, emotional distress, social health, and physical function. The 9 of the 10 PROMIS global measure items will be scored on a Likert scale from 1 to 5, with 5 representing the best health. Higher scores from summation of the nine items indicate better quality of life.

    Time frame: Baseline, 6 months and 12 months

07

Results

Posted Apr 22, 2026
Limitations and caveats
The study had a relatively short follow-up period, a small sample size, and we could not collect information on other physical measures, such as a change in skeletal muscle percentage over a 6-month period

Participant flow

Recruitment was conducted in community-based settings, specifically African immigrant-serving churches located in the Baltimore, Maryland, and Washington, DC metropolitan area.

DPP Intervention (6 Months)
Participant flow — DPP Intervention (6 Months)
MilestoneDPP Immediate Intervention Group First, Then no InterventionNo Intervention First, Then Delayed DPP Intervention Group (6 Months)
Started300
Completed200
Not completed100
Delayed Intervention (6 Months)
Participant flow — Delayed Intervention (6 Months)
MilestoneDPP Immediate Intervention Group First, Then no InterventionNo Intervention First, Then Delayed DPP Intervention Group (6 Months)
Started030
Completed023
Not completed07

Outcome measures

PrimaryChange in Diastolic Blood Pressure (mm/Hg) Over a 6-month Period

Change was calculated as 6 months minus the baseline value

Time frame:
Baseline, 6 months
Reported as:
Mean · mmHg
Change in Diastolic Blood Pressure (mm/Hg) Over a 6-month Period
mmHgImmediate InterventionDelayed Intervention
Change in Diastolic Blood Pressure (mm/Hg) Over a 6-month Period6.1 (2.1 to 10.0)10.3 (5.4 to 15.2)
PrimaryChange in Systolic Blood Pressure (mm/Hg) Over a 6-month Period

Change was calculated as 6 months minus the baseline value

Time frame:
Baseline, 6 months
Reported as:
Mean · mmHg
Change in Systolic Blood Pressure (mm/Hg) Over a 6-month Period
mmHgFirst Intervention GroupDelayed Intervention Group
Change in Systolic Blood Pressure (mm/Hg) Over a 6-month Period9.2 (2.5 to 15.9)11.4 (2.4 to 20.5)
PrimaryChange in Body Weight in Kilograms (kg) Over a 6-month Period

Change was calculated as 6 months minus baseline value

Time frame:
Baseline, 6 months
Reported as:
Mean · kg
Change in Body Weight in Kilograms (kg) Over a 6-month Period
kgImmediate InterventionDelayed Intervention
Change in Body Weight in Kilograms (kg) Over a 6-month Period4.9 (1.0 to 8.7)3.3 (0.01 to 6.5)
PrimaryChange in Body Mass Index Over a 6-month Period

Change was calculated as 6 months minus the baseline value

Time frame:
Baseline, 6 months
Reported as:
Mean · Kg/m^2
Change in Body Mass Index Over a 6-month Period
Kg/m^2First InterventionDelayed Intervention
Change in Body Mass Index Over a 6-month Period1.1 (0.4 to 1.7)0.3 (-1.5 to 2.0)
Other pre-specifiedChange in Quality of Life Over the 12-month Period

A validated tool by the name of PROMIS global measure will be provided by the Patient-Reported Outcomes Measurement Information System (PROMIS). This 9 items on this tool will measure the participants' fatigue, emotional distress, social health, and physical function. The 9 of the 10 PROMIS global measure items will be scored on a Likert scale from 1 to 5, with 5 representing the best health. Higher scores from summation of the nine items indicate better quality of life.

Time frame:
Baseline, 6 months and 12 months

Results for this outcome have not been posted.

Adverse events

Collected over From enrollment up to 12 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Immediate Intervention0/60 (0%)0/60 (0%)0/60 (0%)
Delayed Intervention0/60 (0%)0/60 (0%)0/60 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Immediate Intervention Group First, Then no InterventionNo Intervention First, Then Delayed Intervention GroupTotal
Mean51.1 ± 1.449.7 ± 3.550.6 ± 11.9
Sex: Female, Male
Sex: Female, Male(Participants)Immediate Intervention Group First, Then no InterventionNo Intervention First, Then Delayed Intervention GroupTotal
Female241640
Male61420
Race and Ethnicity Not Collected
Race and Ethnicity Not Collected(Participants)Immediate Intervention Group First, Then no InterventionNo Intervention First, Then Delayed Intervention GroupTotal
Count of participants——0
Participant's Body Mass index category
Participant's Body Mass index category(Participants)Immediate Intervention Group First, Then no InterventionNo Intervention First, Then Delayed Intervention GroupTotal
Normal011
Overweight71219
Obesity231740
Systolic Blood Pressure
Systolic Blood Pressure(mmHg)Immediate Intervention Group First, Then no InterventionNo Intervention First, Then Delayed Intervention GroupTotal
Mean144.4 ± 24.6148.3 ± 14.6146 ± 20.5
Diastolic Blood Pressure
Diastolic Blood Pressure(mmHg)Immediate Intervention Group First, Then no InterventionNo Intervention First, Then Delayed Intervention GroupTotal
Mean94.6 ± 15.797.5 ± 14.395.2 ± 14.0
Glycated hemoglobin (percent)
Glycated hemoglobin (percent)(percentage of glycated hemoglobin)Immediate Intervention Group First, Then no InterventionNo Intervention First, Then Delayed Intervention GroupTotal
Mean5.6 ± 0.15.3 ± 0.15.4 ± 0.1
Body Weight in kilograms (kg)
Body Weight in kilograms (kg)(kg)Immediate Intervention Group First, Then no InterventionNo Intervention First, Then Delayed Intervention GroupTotal
Mean220.1 ± 6.9192.4 ± 192.4206.5 ± 15.3
08

Study locations

1 site
  • Johns Hopkins School of Nursing
    Baltimore, Maryland 21205, United States
09

References and documents

Publications

  • Ogungbe O, Hinneh T, Turkson-Ocran RN, Owusu L, Kumbe B, Spaulding EM, Gbaba S, Assani-Uva A, Mensah J, Yeboah-Kordieh Y, Sinyan A, Ampofo M, Oyedepo F, Commodore-Mensah Y. A Virtual Cardiometabolic Health Program Among African Immigrants in the US: A Pilot Cluster-Randomized Clinical Trial. JAMA Netw Open. 2025 Mar 3;8(3):e2462559. doi: 10.1001/jamanetworkopen.2024.62559. PubMed 40036036 ↗

Study documents

  • Protocol and statistical analysis plan · Sep 14, 2021

Documents are hosted by the registry — open the source record to download them.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05144737
Lead sponsor
Johns Hopkins University
Collaborators
National Institute of Nursing Research (NINR)
Responsible party
Sponsor
First posted
Dec 3, 2021
Start date
Nov 21, 2021
Primary completion
Aug 16, 2024
Completion
Aug 16, 2024
Results posted
Apr 22, 2026
Last update
Apr 23, 2026

Study contacts

Yvonne Commodore-Mensah, PhD, MSH, RN
principal investigator · JHU School Of Nursing

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion